These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2547134)

  • 1. Therapeutic response of breast carcinoma monitored by 31P MRS in situ.
    Ng TC; Grundfest S; Vijayakumar S; Baldwin NJ; Majors AW; Karalis I; Meaney TF; Shin KH; Thomas FJ; Tubbs R
    Magn Reson Med; 1989 Apr; 10(1):125-34. PubMed ID: 2547134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphate metabolites and steroid hormone receptors of benign and malignant breast tumors. A Nuclear Magnetic Resonance study.
    Barzilai A; Horowitz A; Geier A; Degani H
    Cancer; 1991 Jun; 67(11):2919-25. PubMed ID: 1851051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of intra-tumour heterogeneity on the distribution of phosphorus-containing metabolites within human breast tumours: an in vitro study using 31P NMR spectroscopy.
    Smith TA; Glaholm J; Leach MO; Machin L; McCready VR
    NMR Biomed; 1991 Dec; 4(6):262-7. PubMed ID: 1667849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radiotherapy and tamoxifen facilitate breast-preserving treatment of ductal carcinoma in situ of the breast].
    Sautter-Bihl ML
    Strahlenther Onkol; 1999 Dec; 175(12):620-1. PubMed ID: 10633790
    [No Abstract]   [Full Text] [Related]  

  • 5. Ductal carcinoma in situ of the breast.
    Ellison MC; Kenney PJ
    N Engl J Med; 2004 Jul; 351(4):399-402; author reply 399-402. PubMed ID: 15278956
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast cancer therapy in the elderly.
    Aisner J
    JAMA; 1993 Jul; 270(3):391. PubMed ID: 8391087
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic factors and indices in the complex treatment of ductal carcinoma in situ of the breast--review.
    Sedloev T
    Khirurgiia (Sofiia); 2014; (1):23-33. PubMed ID: 25199240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast.
    Solin LJ; Fourquet A; McCormick B; Haffty B; Recht A; Schultz DJ; Barrett W; Fowble BL; Kuske R; Taylor M
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):3-9. PubMed ID: 8083125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen for intraductal cancer.
    Chan KC; Bundred NJ
    Lancet; 1999 Oct; 354(9185):1211-2. PubMed ID: 10513742
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiation therapy for duct carcinoma in situ: who needs radiation therapy, who doesn't?
    McCormick B
    Hematol Oncol Clin North Am; 2013 Aug; 27(4):673-86, vii. PubMed ID: 23915738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant radiotherapy for DCIS.
    Joseph DJ; Spry N; Bydder S
    Lancet; 2000 Jun; 355(9220):2072; author reply 2072-3. PubMed ID: 10885376
    [No Abstract]   [Full Text] [Related]  

  • 12. Current concepts in the treatment of early stage breast cancer.
    Puckett C
    Del Med J; 1992 May; 64(5):313-9. PubMed ID: 1319354
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of the metabolism of human breast cancer spheroids by NMR.
    Ronen S; Degani H
    Magn Reson Med; 1989 Nov; 12(2):274-81. PubMed ID: 2559291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorus-31 metabolism of post-menopausal breast cancer studied in vivo by magnetic resonance spectroscopy.
    Twelves CJ; Porter DA; Lowry M; Dobbs NA; Graves PE; Smith MA; Rubens RD; Richards MA
    Br J Cancer; 1994 Jun; 69(6):1151-6. PubMed ID: 8198985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controversies in breast conservation treatment for breast cancer].
    Motomura K; Egawa C; Komoike Y; Inaji H; Koyama H
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):168-75. PubMed ID: 14997746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O
    Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ductal carcinoma in situ of the breast.
    Brown AP
    N Engl J Med; 2004 Jul; 351(4):399-402; author reply 399-402. PubMed ID: 15269325
    [No Abstract]   [Full Text] [Related]  

  • 18. Is it rational to extend the duration of preventive endocrine treatment in hormone receptor positive ductal carcinoma in situ?
    Altundag K
    J BUON; 2018; 23(3):835. PubMed ID: 30003760
    [No Abstract]   [Full Text] [Related]  

  • 19. [Radiotherapy of breast carcinoma. 2005 version].
    Organgruppe "Mammakarzinom" der DEGRO
    Strahlenther Onkol; 2006 Feb; 182 Suppl 1():4-28. PubMed ID: 16613299
    [No Abstract]   [Full Text] [Related]  

  • 20. Trace elements in noraml and malignant human breast tissue.
    Schwartz AE; Leddicotte GW; Fink RW; Friedman EW
    Surgery; 1974 Aug; 76(2):325-9. PubMed ID: 4367279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.